Overview

• Psilocybin treatment results in significantly higher remission and response rates compared to placebo and other treatments.
• Older patients report greater benefits and experience a 'blissful state' more frequently, potentially due to better emotion management skills.
• The treatment is also linked to improved cognitive performance in older participants, reducing cognitive difficulties.
• Further research is needed to establish psilocybin's clinical use, considering its cost, regulatory challenges, and the need for a controlled environment.
• Studies suggest a strong psychedelic experience is crucial for optimal results, but some patients may find the effects unpleasant.